RCUS · Arcus Biosciences, Inc.
$29.48
+0.62 (+2.15%)
At close · Aug 14
Market Cap
$3.75B
Shares
127.33M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2023 | — | $200,000,000 | — | — | 10-Q , filed 2026-08-05 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2019-12-31 | $94,000 | 10-K, filed 2020-03-05 |
| 2018-12-31 | $0 | 10-K, filed 2020-03-05 |
Key facts
CIK
1724521
CUSIP
03969F109
13F (30d)
217 filings
216 filers
Visit website
Investor relations